EMA accepts Astellas, Seagen's enfortumab vedotin application in urothelial cancer
March 26 2021 - 03:04AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Mar 2023 to Mar 2024